{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:55:04Z","timestamp":1777427704550,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"BITS-Pilani"},{"name":"University Grants Commission, India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejphar.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T14:33:29Z","timestamp":1397831609000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models"],"prefix":"10.1016","volume":"735","author":[{"given":"Deepali","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devadoss","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshwant","family":"Kurhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.04.008_bib1","series-title":"Handbook of Treating Variants and Complications in Anxiety Disorders","first-page":"243","article-title":"Treatment of Comorbid Depression","author":"Abramowitz","year":"2013"},{"key":"10.1016\/j.ejphar.2014.04.008_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2014.04.008_bib3","series-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","article-title":"Monoamine Hypothesis of Mood Disorders","author":"Barchas","year":"1999"},{"key":"10.1016\/j.ejphar.2014.04.008_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002130050568","article-title":"mCPP-induced anxiety in the light\u2013dark box in rats\u2013a new method for screening anxiolytic activity","volume":"136","author":"Bilkei-Gorzo","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(92)90186-8","article-title":"Behavioral studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety","volume":"218","author":"Bill","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib6","first-page":"212","article-title":"Action of caffeine on the spontaneous motility of the mouse","volume":"158","author":"Boissier","year":"1965","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib8","first-page":"178","article-title":"Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice","volume":"27","author":"Bourin","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.008_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pbb.2006.09.003","article-title":"Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test","volume":"85","author":"Bravo","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2014.04.008_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/da.1070","article-title":"Infrequency of pure GAD: impact of psychiatric comorbidity on clinical course","volume":"14","author":"Bruce","year":"2001","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2014.04.008_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Castagne","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.008_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrn1629","article-title":"Is mood chemistry","volume":"6","author":"Castren","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.008_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0091-3057(89)90033-6","article-title":"Exploration of mice in a black and white test box: validation as a model of anxiety","volume":"32","author":"Costall","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0773.1992.tb00448.x","article-title":"Anxiolytic potential of 5\u2010HT3 receptor antagonists","volume":"70","author":"Costall","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","article-title":"Exploratory behavior models of anxiety in mice","volume":"9","author":"Crawley","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.04.008_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2014.04.008_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/da.10146","article-title":"Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study","volume":"19","author":"Davidson","year":"2004","journal-title":"Depress. Anxiety"},{"issue":"Suppl. 6","key":"10.1016\/j.ejphar.2014.04.008_bib21","first-page":"S7","article-title":"Depression: the case for a monoamine de\ufb01ciency","volume":"61","author":"Delgado","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1734-1140(10)70263-2","article-title":"Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl)(quinoxalin-2-yl) methanone, a novel 5-HT (3) receptor antagonist, in animal models of depression","volume":"62","author":"Devadoss","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2014.04.008_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","article-title":"Neuronal plasticity and survival in mood disorders","volume":"48","author":"Duman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.mp.4001314","article-title":"Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","volume":"8","author":"Eisensamer","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1476-5381.1994.tb13140.x","article-title":"Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones","volume":"112","author":"Fan","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2013.05.006","article-title":"Antidepressant\u2013like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behavior based rodent models: evidence for the involvement of serotonergic system","volume":"109","author":"Gautam","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib28","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1523\/JNEUROSCI.4287-11.2012","article-title":"Olfactory deficits cause anxiety-like behaviors in mice","volume":"32","author":"Glinka","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.008_bib29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0003-3472(74)90008-6","article-title":"Sex differences in emotional behavior in rat: correlation between open field defecation and active avoidance","volume":"22","author":"Gray","year":"1974","journal-title":"Anim. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0278-5846(00)00151-2","article-title":"The mouse ligth-dark paradigm: a review","volume":"25","author":"Hascoet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"Olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.04.008_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.euroneuro.2005.10.001","article-title":"Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice","volume":"16","author":"Kos","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7742(08)60295-0","article-title":"Anatomical, physiological and behavioral aspects of olfactory bulbectomy in the rat","volume":"22","author":"Leonard","year":"1981","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pnpbp.2009.03.004","article-title":"Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system","volume":"33","author":"Machado","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.2042-7158.1978.tb13237.x","article-title":"How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated","volume":"30","author":"MacKay","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2014.04.008_bib38","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1016\/j.bmcl.2010.08.128","article-title":"Design, synthesis and structure\u2013activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression","volume":"20","author":"Mahesh","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2014.04.008_bib39","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1139\/cjpp-2013-0134","article-title":"2-(4-substituted piperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models","volume":"91","author":"Mahesh","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2011.05.075","article-title":"Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative \u2013 an investigation using behavioral tests battery of depression","volume":"409","author":"Mahesh","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.04.008_bib41","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.bmcl.2004.07.060","article-title":"Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists","volume":"14","author":"Mahesh","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2014.04.008_bib42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0278-5846(89)90061-4","article-title":"Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice","volume":"13","author":"Martin","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.008_bib43","series-title":"The Global Burden of Disease: 2004 Update","author":"Mathers","year":"2008"},{"key":"10.1016\/j.ejphar.2014.04.008_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)29416-7","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"Mork","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-8993(97)01459-5","article-title":"The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats","volume":"786","author":"Nakagawa","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.04.008_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1113\/jphysiol.1968.sp008392","article-title":"The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips","volume":"194","author":"Paton","year":"1968","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004850-200505000-00003","article-title":"Escitalopram and suicidality in adult depression and anxiety","volume":"20","author":"Pedersen","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib50","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0269881109348161","article-title":"The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target","volume":"24","author":"Rajkumar","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FBP.0b013e3282f3cfd4","article-title":"Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models","volume":"19","author":"Ramamoorthy","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"S1","key":"10.1016\/j.ejphar.2014.04.008_bib54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2014.04.008_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-3057(96)00402-9","article-title":"Risk assessment Hewlettior: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test","volume":"57","author":"Rodgers","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.04.008_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-009-1539-y","article-title":"Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression","volume":"205","author":"Romeas","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib57","first-page":"107","article-title":"Anti-anxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model","volume":"19","author":"Roychoudhury","year":"1997","journal-title":"Method Find. Exp. Clin."},{"key":"10.1016\/j.ejphar.2014.04.008_bib58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomized rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.04.008_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressant drugs","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.008_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.11.4.527","article-title":"The 5-HT3 receptor as a therapeutic target","volume":"11","author":"Thompson","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2014.04.008_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1176\/appi.psy.42.3.258","article-title":"Possible serotonin syndrome in association with 5-HT3 antagonist agents","volume":"42","author":"Turkel","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ejphar.2014.04.008_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-4328(00)00240-0","article-title":"Behavioral analysis of four mouse strains in an anxiety test battery","volume":"115","author":"Van Gaalen","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.04.008_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0163-7258(90)90043-2","article-title":"Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats","volume":"47","author":"Van Riezen","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.04.008_bib65","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbr.2007.01.003","article-title":"Behavioral and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety","volume":"178","author":"Wang","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.04.008_bib66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.008_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2004.10.040","article-title":"Olfactory bulbectomy in mice induces alterations in exploratory behavior","volume":"374","author":"Zueger","year":"2005","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400288X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400288X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:26:59Z","timestamp":1746188819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400288X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":67,"alternative-id":["S001429991400288X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.008","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}